MCRB
Seres Therapeutics, Inc.stockNASDAQ
seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.70 | 2026-11-09 | -6.59% | 0.678 |
| 1M | 2.46 | 2026-10-16 | -35.45% | -0.400 |
| 3M | 4.51 | 2026-08-17 | -64.79% | 0.425 |
| 6M | 7.64 | 2026-05-15 | -79.22% | 0.406 |
| 1Y | 21.64 | 2025-11-17 | -92.66% | 1.304 |
| 2Y | 10.99 | 2024-11-15 | -85.56% | — |
| 5Y | 163.60 | 2021-11-16 | -99.03% | 1.194 |
Seres Therapeutics, Inc. (NASDAQ:MCRB) stock price today is $1.59, and today's volume is 18,970. MCRB is up 13.421% today. The 30 day average volume is 83,444. MCRB market cap is $16.19M with 10.20M shares outstanding.
